These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12561053)

  • 1. Diagnostic evaluation of developmental delay/mental retardation: An overview.
    Battaglia A; Carey JC
    Am J Med Genet C Semin Med Genet; 2003 Feb; 117C(1):3-14. PubMed ID: 12561053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic yield of the comprehensive assessment of developmental delay/mental retardation in an institute of child neuropsychiatry.
    Battaglia A; Bianchini E; Carey JC
    Am J Med Genet; 1999 Jan; 82(1):60-6. PubMed ID: 9916845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging studies in the evaluation of developmental delay/mental retardation.
    Battaglia A
    Am J Med Genet C Semin Med Genet; 2003 Feb; 117C(1):25-30. PubMed ID: 12561055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical genetic evaluation of the child with mental retardation or developmental delays.
    Moeschler JB; Shevell M;
    Pediatrics; 2006 Jun; 117(6):2304-16. PubMed ID: 16740881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation and diagnosis of patients with developmental delay: standardised protocols from the paediatric point of view].
    Poch-Olivé ML
    Rev Neurol; 2006 Jan; 42 Suppl 1():S99-S102. PubMed ID: 16506141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global developmental delay and mental retardation or intellectual disability: conceptualization, evaluation, and etiology.
    Shevell M
    Pediatr Clin North Am; 2008 Oct; 55(5):1071-84, xi. PubMed ID: 18929052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical consult: developmental delay/fragile X syndrome.
    Wiesner GL; Cassidy SB; Grimes SJ; Matthews AL; Acheson LS
    Prim Care; 2004 Sep; 31(3):621-5, x. PubMed ID: 15331251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation.
    Stankiewicz P; Beaudet AL
    Curr Opin Genet Dev; 2007 Jun; 17(3):182-92. PubMed ID: 17467974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic microarrays in clinical diagnosis.
    Veltman JA
    Curr Opin Pediatr; 2006 Dec; 18(6):598-603. PubMed ID: 17099357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies.
    Edelmann L; Hirschhorn K
    Ann N Y Acad Sci; 2009 Jan; 1151():157-66. PubMed ID: 19154522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic evaluation of intellectual disabilities.
    Moeschler JB
    Semin Pediatr Neurol; 2008 Mar; 15(1):2-9. PubMed ID: 18342255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiologic evaluation of genetically-caused mental retardation. Diagnostic algorithm and new molecular techniques].
    del Valle Torrado M
    Arch Argent Pediatr; 2009 Jun; 107(3):246-55. PubMed ID: 19543634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of pervasive developmental disorders without mental retardation and its impact on obtaining social and educational services in Quebec].
    Mottron L; Lapointe P; Fournier F
    Sante Ment Que; 1998; 23(1):96-114. PubMed ID: 9775956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presenting phenotype and clinical evaluation in a cohort of 22 Williams-Beuren syndrome patients.
    Ferrero GB; Biamino E; Sorasio L; Banaudi E; Peruzzi L; Forzano S; di Cantogno LV; Silengo MC
    Eur J Med Genet; 2007; 50(5):327-37. PubMed ID: 17625998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in molecular cytogenetics for the evaluation of mental retardation.
    Xu J; Chen Z
    Am J Med Genet C Semin Med Genet; 2003 Feb; 117C(1):15-24. PubMed ID: 12561054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving genetic health care: a Northern New England pilot project addressing the genetic evaluation of the child with developmental delays or intellectual disability.
    Moeschler JB; Amato RS; Brewster T; Burke L; Dinulos MB; Smith R; Smith W; Miller P
    Am J Med Genet C Semin Med Genet; 2009 Aug; 151C(3):241-54. PubMed ID: 19621460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
    Battaglia A; Hoyme HE; Dallapiccola B; Zackai E; Hudgins L; McDonald-McGinn D; Bahi-Buisson N; Romano C; Williams CA; Brailey LL; Zuberi SM; Carey JC
    Pediatrics; 2008 Feb; 121(2):404-10. PubMed ID: 18245432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yield of additional metabolic studies in neurodevelopmental disorders.
    Engbers HM; Berger R; van Hasselt P; de Koning T; de Sain-van der Velden MG; Kroes HY; Visser G
    Ann Neurol; 2008 Aug; 64(2):212-7. PubMed ID: 18570304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.